Artificial intelligence in pharma, health care: at the crossroads of hype and reality

Artificial intelligence is at the forefront of the minds of many pharmaceutical and health care executives. We know this because, as life sciences consultants, our clients frequently ask us for advice on how best to navigate AI. But along with enthusiasm in areas as diverse as phenotypic screening, drug repositioning, and analysis of CT scans, we are also finding a growing skepticism: What is real and what is hype?